Judge Wears VR Headset To View Defendant’s Account Of Events And What Fresh Hell Is This? – Above the Law

Screencap
from
WPLG
10
YouTube
channel

In
a
new
dystopian
hell
unleashed
upon
the
country
from

*checks
notes
unnecessarily*

Florida,
a
judge
has
allowed
lawyers
to
use
a
virtual
reality
presentation
to
show
an
immersive
representation
of
the
defendant’s
perspective
in
a

*checks
notes
unnecessarily
again*

Stand
Your
Ground
case.

It’s
like
a
VR
mod
for
Grand
Theft
Auto
but
real!

Defendant
owns
an
event
venue
and
claims
that
violence
broke
out
at
a
wedding
and
when
he
tried
to
break
it
up,
a
crowd
of
revelers
cornered
him
to
yell
at
him
and
he
decided
to
pull
a
gun
on
them.
Making
this
less
a
First-Person
Shooter
(FPS)
than
a
First-Person
Threatening
Shooter
(FPTS).
Which
might
sound
like
aggravated
assault
with
a
deadly
weapon
trial
and
an
affirmative
defense
of
acting
in
self-defense,
but
Florida
short-circuits
that
process
with
a
Stand
Your
Ground
law
that
allows
the
judge
to
make
a
preemptive
determination
that
if
the
defendant
“reasonably
believes
that
using
or
threatening
to
use
such
force
is
necessary
to
prevent
imminent
death
or
great
bodily
harm,”
the
charge
can
get
tossed
without
a
trial.

During
the
testimony
of
the
defense
expert…
wait,
hold
on.
What
kind
of
“expert”
is
there
for
“this
is
an
acceptable
time
to
wave
a
gun
at
people”
testimony?
Do
you
need
to
do
post
baccalaureate
work
for
that
gig?
Not
knocking
expert
testimony
generally,
but
usually
it’s
focused
on
complex
questions
of
science
or
methodology
and
not
“in
my
professional
opinion
as
an
employee
of
the
defense,
I
believe
the
defendant
was
justified
in
doing
the
exact
thing
he’s
charged
with
doing.”

Anyway,
the
defense
expert
testified
about
the
defendant’s
account
of
events
and
had
a
visual
aide
to
go
with
it.

Screenshot 2025-01-09 at 12.43.20 PM

Screencap
from
WPLG
10
YouTube
channel

I
want
my
MTV

he’s
presumably
yelling.

This
is
goofy
and
dumb,
seeing
as
it
adds
nothing
probative
to
a
standard
testimonial
account.
It’s
still
the
defendant’s
account
of
events
just
rendered
like
it’s
The
Sims
4
Florida
Man
Expansion
Pack.

Seriously,
someone
please
take
these
video
clips
and
superimpose
the
original
Sims
sounds
on
them.

But
while
the
third-person
perspective
is
unnecessary,
it’s
the
first-person
account
that
introduces
an
overwhelming
prejudicial
effect
by
placing
the
viewer

in
this
case
the
judge
and
in
a
future
nightmare
scenario
a
jury

in
the
place
of
the
defendant
living
out
the
events
from
sole
perspective
of
the
defendant.

Screenshot 2025-01-09 at 1.11.03 PM

Screencap
from
WPLG
10
YouTube
channel

There
is,
the
defense
hopes,
a
closing
of
psychological
distance
and
a
sharp
uptick
in
empathy
if
the
fact-finder
is
placed
behind
the
defendant’s
eyes
and
can
really
see
8-bit
representations
of
stereotypes
closing
in
on
them.
To
the
judge’s
credit,
he
seems
skeptical
about
handing
this
evidence
to
the
jury,
but
given
the
Florida
law,
it
might
not
even
come
to
that.
We
trust
judges
to
be
able
to
intellectually
wall
off
evidence
that’s
more
prejudicial
than
probative,
but
the
trick
of
this
tactic
is
to
confuse
the
brain
into
failing
to
see
anything
prejudicial
about
this
at
all.

And
will
the
state
have
an
opportunity
to
animate
its
own
counter-narrative?
Outside
of
CBS
Primetime,
law
enforcement
doesn’t
have
infinite
computing
power
and
plucky
out-of-work
game
designers
in
darkened
rooms
back
at
the
station.

GameRant
has
an
appropriately
technophilic
response
:

This
particular
demonstration
likely
would
have
been
deemed
impractical
without
the
wireless
capabilities
of the
Meta
Quest
VR
line
.
Meta
Quests
can
be
simply
put
on
and
immediately
used
anywhere,
whereas
other
VR
headsets
require
a
wired
connection
to
a
PC,
and
possibly
external
trackers
to
determine
where
a
user
is
standing
and
looking.
With
the
potential
to
create
empathy
and
understanding
for
a
defendant’s
perspective
and
mindset
through
VR
experiences
like
this
one,
it’s
possible
that
Meta
could
see
widespread
adoption
of
its
headsets
by
legal
teams
in
the
future.

The
deck
is
improperly
stacked
against
defendants
in
a
whole
host
of
ways
but
this
ain’t
it.
Public
defenders
aren’t
getting
Quest
goggles
and
laid
off
game
designers
any
time
soon.
This
just
hands
affluent
defendants
a
tool
for
creating
a
computer-generated
first-person
representation
of
their
story
without
direct
refutation
while
poor
defendants
are
drawing
stick
figures
on
napkins.

It
may
well
“create
empathy
and
understanding
for
a
defendant’s
perspective”
but
in
all
the
ways
the
justice
system
is
designed
to
weed
out.
Court
is
supposed
to
be
boring
because
it’s
supposed
to
sap
the
highly
charged
events
of
emotion
for
dispassionate
evaluation.
It’s
why
victims’
rights
initiatives
are
problematic
too…
we
don’t
let
victims
level
vigilante
justice
for
a
reason.
This
tech
just
endeavors

and
if
the
graphics
were
more
Apple
Vision
Pro
than
Meta
Quest
2
it
might
succeed

to
tilt
the
passions
toward
one
side
of
the
story.

It’s
also
not
necessarily
going
to
help
out
the
defendants
as
much
as
idealists
might
hope.
VR
will
create
empathy
and
understanding
for
whichever
side
has
the
money
to
exploit
it.
The
state
may
not
have
the
funds
to
do
this
in
every
case,
but
rich
victims
can.
Whether
that
works
its
way
into
criminal
cases
or
skews
later
civil
trials,
there’s
profound
danger
for
the
justice
system
in
this
tech.

I’m
one
of
the
people
who
believes
in
wearable
tech,
and
I
think
future
iterations
of
these
goggles

especially
the
too-expensive-right-now
Vision
Pro

have
a
place
in
legal
work
as
confidential,
eyes-only
workspaces
and
expansive
canvasses
for
review.
They
might
even
fit
in
courtrooms
if
they
allowed
exploration
of
mutually
stipulated
upon
settings.

But
a
pre-trial
Stand
Your
Ground
hearing
where
the
defendant
tries
to
establish
that
their
subjective
account
of
events
inspired
reasonable
fear
is
the
most
Kafkaesque
possible
use.




HeadshotJoe
Patrice
 is
a
senior
editor
at
Above
the
Law
and
co-host
of

Thinking
Like
A
Lawyer
.
Feel
free
to email
any
tips,
questions,
or
comments.
Follow
him
on Twitter or

Bluesky

if
you’re
interested
in
law,
politics,
and
a
healthy
dose
of
college
sports
news.
Joe
also
serves
as
a

Managing
Director
at
RPN
Executive
Search
.

Top 20 Biglaw Firm Announces Bonus Structure For Associates – Above the Law

We
may
be
beyond
the
time
that
Larry
David
believes
it’s
acceptable
to
wish
someone
a
happy
new
year,
but
that
doesn’t
mean
2024
is
completely
forgotten
in
Biglaw.
Especially
not
when
there
are
bonuses
still
to
give
out.

Today,
Goodwin
Procter

a
firm
with
over
$2
billion
in
gross
revenue,
making
it
#16
on
the
Am
Law
100

announced
bonuses.

As
with
the
tippy
top

of
Biglaw
firms,
Goodwin
is
giving
out
both
annual
bonuses
as
special
bonuses
to
reward
associates
for
all
their
hard
work
last
year.

The
bonus
schedule
at
Goodwin
is
as
follows:


Salary
Class

Bonus

Special
Bonus

2023
$20,000 $6,000

2022
$30,000 $10,000

2021
$57,500 $15,000

2020
$75,000 $20,000

2019
$90,000 $25,000

2018
$105,000 $25,000

2017+
$115,000 $25,000

Bonuses
will
be
paid
on
January
24th.
Associates
who
billed
at
least
1,950
hours
during
the
last
fiscal
year
are
eligible
for
bonuses.
Pro
bono
time
and
up
to
100
hours
of
Culture
&
Innovation
(marketing
activities,
knowledge
management,
Business
Unit
and
Legal
Practice
Area
initiatives,
diversity
initiatives,
training
and
participation
on
firm
committees)
count
towards
that
threshold.
Full
memo
available
on
the

next
page
.

Remember
everyone,
we
depend
on
your
tips
to
stay
on
top
of
important
bonus
updates,
so
when
your
firm
matches,
please
text
us
(646-820-8477)
or email
us
 (subject
line:
“[Firm
Name]
Matches”).
Please
include
the
memo
if
available.
You
can
take
a
photo
of
the
memo
and
send
it
via
text
or
email
if
you
don’t
want
to
forward
the
original
PDF
or
Word
file.

And
if
you’d
like
to
sign
up
for
ATL’s
Bonus
Alerts
(which
is
the
alert
list
we
also
use
for
salary
announcements),
please
scroll
down
and
enter
your
email
address
in
the
box
below
this
post.
If
you
previously
signed
up
for
the
bonus
alerts,
you
don’t
need
to
do
anything.
You’ll
receive
an
email
notification
within
minutes
of
each
bonus
announcement
that
we
publish.
Thanks
for
all
of
your
help!




Kathryn
Rubino
is
a
Senior
Editor
at
Above
the
Law,
host
of

The
Jabot
podcast
,
and
co-host
of

Thinking
Like
A
Lawyer
.
AtL
tipsters
are
the
best,
so
please
connect
with
her.
Feel
free
to
email

her

with
any
tips,
questions,
or
comments
and
follow
her
on
Twitter

@Kathryn1
 or
Mastodon

@[email protected].


Bonus Time

Enter
your
email
address
to
sign
up
for
ATL’s

Bonus
&
Salary
Increase
Alerts
.


The Great Escape: Nonlegal Careers For Lawyers – Above the Law

(Photo
by
Taylor
Hill/Getty
Images)



Ed.
note
:
This
is
the
first
in
a
series
of
articles
by
our
friends
Neil
Handwerker
and
Kimberly
Fine
of

ex
judicata
,
who
will
be
writing
about
lawyers
interested
in
transitioning
to
nonlegal
careers.


The
wave
of
lawyers
and
law
students
interested
in
leaving
law
for
new
careers
continues
to
grow
exponentially. 
It
was
with
that
tailwind
that
we
launched
ex
judicata
in
July
of
2023.  


ex
judicata
Hypothesis:
“Every
practicing
lawyer
knows
at
least
two
other
practicing
lawyers
who
would
like
to
leave
law
for
a
new
career.”


ex
judicata
Hypothesis
#2:
“Every
civilian
knows
at
least
one
practicing
lawyer
*

who
would
like
to
leave
law
for
a
new
career.”


*
My
cousin,
my
friend,
my
ex-wife,
my
brother-in-law
“…is
a
lawyer
and
they…” 


ex
judicata
was
designed
to
be
the
first
total
solution
for
lawyers
and
law
students
interested
in
leaving
law
for
new
careers. 
Here
are
the
Top
10
things
we
have
learned
to
date:


1.
Against
“recovery”


Lawyers
who
have
left
law
and
friends
and
family
of
lawyers
who
have
left
law
use
the
phrase
“recovering
lawyer”
accompanied
with
a
chuckle
way
too
much.
There
are
three
problems
with
this.


Not
funny. 
Not
original
and
to
quote
the
mighty
Gabriel
Byrne
in



The
Usual
Suspects,
You’re
missing
the
point!” 
You
are
always
a
lawyer
and
should
be
proud
of
all
you
have
accomplished. 
This
is
just
a
new
chapter
where
you
will
still
be
calling
on
your
JD
skill
set.


We
had
the
pleasure
of
interviewing
Professor
Scott
Westfahl
at
Harvard
Law
School
last
year. 
He
told
us:
“When
I
left
my
law
firm
for
a
nonlegal
job,
I
had
a
lot
of
people
asking
me
at
the
time,
‘What
are
you
doing?
You’re
throwing
away
your
10
years
of
practice
and
your
law
degree.’
I’m
like
absolutely
not,
because


I


knew
I
could
leverage
all
my
experiences
to
do
well
on
my
new
chosen
career
path.”


2.
Two
converging
themes
driving
the
exodus


Lawyers
who
have
hit
the
wall
and/or
dislike
practicing
law
and
want
to
find
something
else.


Lawyers
who
enjoy
practicing
law
but
would
like
to
move
to
a
career
more
in
line
with
their
passions
and/or
lifestyle. 
Never
has
the
entire
world
of
work
been
more
transparent. 
Lawyers
and
law
students
are
embracing
the
chance
to
use
their
JD
skill
set
in
alternative
careers.


3.
Never
too
late
for
a
Second
Act


While
most
of
the
activity
is
younger
lawyers
in
law
firms
and
law
departments
pivoting,
there
is
a
growing
base
of
older,
more
experienced
lawyers
who
want
to
make
a
change. 
We
are
seeing
this
most
often
in
partners,
say
55
and
above,
who
have
already
enjoyed
a
successful
legal
career. 
They
want
a
Second
Act.


The
following
example
is
illustrative:
We
were
tasked
by
Marsh
&
McLennan
to
find
a
senior
bankruptcy
partner
at
a
major
law
firm
to
come
aboard
in
a
newly
created
nonlegal
job
in
their
Global
Turnarounds
Group. 
We
placed
a
Paul
Weiss
partner,
Alan
Kornberg,
in
the
position,
thankful
for
this
unimagined
Second
Act.


4.
The
JD
ain’t
what
it
used
to
be


The
definition
of
a
JD
degree
in
the
American
work
force
is
evolving.


Old: 
A
JD
is
a
law
degree.


New:
A
JD
is
a
foundation
for
myriad
careers. 
Law
being
just
one
of
many
paths.


Kellye
Testy
is
the
Executive
Director
&
CEO
of
the
Association
of
American
Law
Schools
(AALS)
and
widely
perceived
to
be
the
most
influential
person
in
legal
education. 
One
of
her
mandates
is
expanding
the
universe
of
opportunity
for
law
students
beyond
the
traditional
practice
of
law. 
She
gave
us
the
following
definition
which
we
have
co-opted
and
use
all
the
time. 
“A
JD
is
a
degree
in
complex
problem-solving. 
And
if
there
is
one
thing
the
world
needs
more
of,
it
is 
complex
problem-solvers.”


5.
Asked
and
answered


In
LinkedIn
polls
we
have
conducted
asking
“What
is
holding
you
back
from
leaving
law?”
the
answers
rank
as
follows:


  1. Economics.
    Can’t
    afford
    a
    cut
    in
    pay

  2. Fear
    of
    change

  3. Don’t
    know
    what
    else
    to
    do

  4. Perceived
    loss
    of
    prestige


6.
However….


Yet,
hands
down,
the
question
we
have
gotten
most
often
since
starting
ex
judicata
is
“Where
do
I
even
begin?
(to
try
to
find
a
new
career).”
Nothing
to
do
with
how
to
afford
to
make
a
change
or
tips
to
overcoming
fear.  


This
may
make
sense
as,
anecdotally,
we
have
found
in
working
one-on-one
with
lawyers,
if
we
help
them
isolate
a
career
more
in
line
with
their
passions
and
purpose,
money
questions
and
fear
become
much
more
manageable.


7.
Know
thy
coach


There
are
a
boatload
of
lawyer
coaches
out
there
who
will
show
you
how
to
leave
law. 
There
is
nothing
new
here. 
Back
in
2014,
Liz
Brown
in
her
book,




Life
After
Law:
Finding
Work
You
Love
with
the
JD
You
Have
,
came
up
with
this
wonderful
sentence,
which
we’ve
seen
so
many
people
use
as
if
they
just
came
up
with
it: 
“Law
is
the
only
career
that
has
a
sub-profession
dedicated
to
helping
people
get
out
of
it.”


Here’s
the
problem. 
These
lawyer
coaches
fall
into
three
categories
and
one
can
easily
get
lost
in
the
noise.


  • Well-meaning
    people
    who
    genuinely
    want
    to
    help
    fellow
    lawyers
    get
    out
    but
    have
    no
    concrete
    plan
    as
    to
    how
    one
    actually
    does
    this
    or
    actual
    jobs
    their
    clients
    can
    apply
    for.

  • Not-so
    well-meaning
    people
    who
    see
    this
    as
    an
    easy
    way
    to
    make
    money
    since
    there
    are
    so
    many
    unhappy
    practicing
    lawyers.

  • People
    with
    solid
    advice,
    suggested
    jobs
    to
    apply
    for,
    and
    a
    track
    record
    of
    helping
    fellow
    lawyers
    leave
    law
    for
    successful
    new
    careers.


8.
The
ABA
is
behind
the
curve


The
ABA
has
been
slow
to
get
onboard. 
All
you
really
need
to
know
is
that
the
lead
article




Nine
Non-Legal
Jobs
You
Can
(Really,
Truly)
Do
with
a
Law
Degree


on
the
ABA’s
Alternative
Career
site
spells
“nonlegal”
wrong. 
The
most
up-to-date
piece
under
“latest
resources”
is
dated
October
4,
2023.


9.
(Some)
law
schools
are
with
it


The
law
schools



are


acknowledging
the
growing
desire
of
some
students
for
alternative
careers



right
out
of
law
school,


with
more
and
more
actually
starting
law
school
knowing
they
don’t
want
to
practice. 
The
most
enlightened
law
schools
like
Michigan
State
and
Northeastern
even
have
programs
designed
for
students
graduating
into
law
adjacent
fields
like
legal
ops
and
legal
tech.


10.
Firms
forget 


Am
Law
100
firms
have
been
pouring
millions
into
alumni
programs
designed
to
keep
better
track
of
their
alumni,
provide
networking,
and
keep
them
in
the
family. 
Most
programs
fall
short,
with
alumni
working
in
nonlegal
careers
an
afterthought. 
But
a
few
law
firms
we
are
working
with
realize
that,
if
cultivated
properly,
alumni
no
longer
practicing
law
can
be
a
secret
weapon
in
driving
referrals
back
to
the
mothership.




Neil
Handwerker
and
Kimberly
Fine
are
the
co-founders
of

ex
judicata
,
a
website
providing
information,
resources,
webinars,
coaching,
money
management,
and
inspirational
content
for
lawyers
and
law
students
interested
in
moving
to
nonlegal
careers. 
This
is
their
second
startup
together.
Feel
free
to

email
 them
with
any
questions
or
suggestions
or
connect
with
them
on LinkedIn.

Sam Alito Offers Flimsy Excuse For Conversation With Donald Trump – Above the Law

(Photo
by
Ali
Shaker/VOA)

Donald
Trump
just
asked
the
Supreme
Court
to
intervene
in
his
New
York
state
criminal
case
and
extend
its
newly
expanded
presidential
immunity
just
a
little
further
to
cover
illegally
concealing
a
hush
money
scheme
to
pay
off
an
adult
film
star
before
he
ever
became
president.
A
matter
of
hours
before
that
case


number
666
because
you
cannot
make
this
stuff
up


arrived
at
the
Court,
Trump
had
a
phone
conversation
with
Justice
Sam
Alito.

You
know,
just
the
kind
of
light-hearted
catch-up
you
have
with
your
bros
right
before
asking
them
to
suspend
the
criminal
code
for
you.

In
his
remarks
about
the
call,
Alito
puts
a
lot
of
weight
on
the
fact
that
it
took
place
before
Trump
filed
his
application.
Alito
seems
to
think
this
means
he
had
no
way
of
predicting
a
potential
conflict
when
all
it
really
seems
to
say
is
“Trump
decided
this
was
worth
filing
after
checking
in
on
Alito.”

While
the
emergency
filing
over
the
NY
case
hadn’t
hit
the
docket
yet,
Trump
already
had
business
before
the
Court
with
his
half-baked
effort
to
halt
the
planned
TikTok
ban
from
going
into
effect,
presumably
so
he
can
try
to
exact
some
sort
of
personal
vig
from
the
company.
But
since

Alito
doesn’t
think
it’s
a
problem
to
go
on
a
vacation
with
litigants
with
business
before
him
,
a
telephone
call
with
a
litigant
certainly
wouldn’t
raise
any
flags
for
him.

And
we
know
his
thoughts
on
flags.

“William
Levi,
one
of
my
former
law
clerks,
asked
me
to
take
a
call
from
President-elect
Trump
regarding
his
qualifications
to
serve
in
a
government
position,”
Justice
Alito
told
ABC
News.
“I
agreed
to
discuss
this
matter
with
President-elect
Trump,
and
he
called
me
yesterday
afternoon.”

On
the
one
hand,
an
employer
checking
references
is
a
reasonably
innocuous
explanation.
On
the
other
hand,
this
might
be
the
least
believable
excuse
Alito
could
have
cooked
up.

Levi
almost
certainly
came
up
during
the
call.
He
might’ve
even
been
the
subject
superficially
the
whole
time.
But
it’s
a
special
kind
of
gullible
to
believe
this
call
wasn’t
really
about
Trump’s
legal
interests.
“No
one
is
questioning
Levi’s
credentials,
which
are
as
good
as
can
be,”
says
Fix
the
Court’s
Gabe
Roth.
“The
call
was
merely
an
excuse
for
Trump
to
speak
with
one
of
the
nine
people
determining
the
fate
of
his
hush
money
sentencing
in
the
coming
days
and
who
will
review
many
more
Trump-related
issues
over
the
next
four
years.”
It’s
also
unnecessary
when
Alito
could’ve
responded
to
the
ethically
fraught
request
with
a
letter
explaining
why
he
couldn’t
take
the
call
but
reaffirming
his
faith
in
his
former
clerk.

The
call
makes
even
less
sense
when
you
consider
that
Trump’s
barely
vetting
his
cabinet
secretaries.
Trump
didn’t
feel
the
need
to
check
Matt
Gaetz’s
public
Venmo
feed
but
feels
the
need
to
personally
check
references
on
whatever
middling
job
he’s
giving
Bill
Barr’s
former
chief
of
staff?
Industrial-grade
credulity
cannot
hold
up
to
this
kind
of
strain.

Alito
claims
the
conversation
never
strayed
into
Trump’s
upcoming
Supreme
Court
cases.
There’s
no
record
of
what
transpired
on
the
call,
but
we
should
totally
take
him
at
his
word.
It’s
not
like
he
said
in
2023
that
he
barely
knew
Paul
Singer,
the
billionaire
litigant
giving
him
a
free
private
plane
trip,
even
though
back
in
2009,

ABOVE
THE
LAW
contemporaneously
reported

on
an
event
where
Alito
was
introduced
by
his
personal
friend…
Paul
Singer.
I
mean,
a
guy
who
tried
to
mislead
the
public
on
such
an
easily
checked
matter
like
that
would
be
a
thoroughly
unreliable
narrator
about
his
own
ethical
issues!

Trump
wanted
to
take
Alito’s
temperature

directly
or
indirectly

and
found
a
justice
more
than
willing
to
comply
with
this
request.
Alito
should
recuse
himself
from
Trump’s
case
given
this
revelation
about
his
stunning
lack
of
judgment.
But
he
won’t
because
while
the

Trump
v.
United
States

opinion
is
reported
as
a
6-3
supermajority
providing
necessary
slack
for
Alito
to
sit
out
and
still
deliver
for
“the
Boss,”
it’s
not
so
simple.
Trump’s
attack
on
the
New
York
criminal
case
arises

in
part

from
the
section
of
the

Trump

opinion
suggesting
unofficial
acts
can
earn
immunity
if
any
of
the
evidence
involves
an
official
act
and
Trump’s
arguing
that
testimony
from
White
House
aides
about
what
he
did

after

the
fact
with
the
crime
that
took
place

before

becoming
president
should
nix
the
whole
case.
And
on

that

issue,
Amy
Coney
Barrett
refused
to
hop
aboard,
making
it
much
closer
to
a
5-4
question.

If
the
Chief
Justice
wants
the
public
to
regain
faith
in
the
legitimacy
of
the
courts,
this
might
be
a
good
place
to
start.
Even
assuming
an
entirely
innocent
phone
call
this
time

a
big
ask

if
Alito
hears
this
case,
it
establishes
a
precedent
for
Trump
to
have
private
chit-chats
with
the
justices
with
no
consequences.
The
risk
of
mischief
is
extraordinary.

This
is
where
that
whole
“avoid
the
mere
appearance
of
impropriety”
thing
would
come
into
play.
Except
this
Court
reads
that
classic
maxim
a
little
differently
these
days:
avoid
the
mere

appearance

of
impropriety.


[UPDATE
:
I
hastily
wrote
“Peter”
Singer
in
the
first
draft,
apparently
confusing
billionaire
Paul
Singer
with
bioethicist
and
moral
philosopher
Peter
Singer
which
probably
says
something
but
I’m
not
sure
what
it
is.]


Trump
speaks
with
Justice
Alito
amid
push
to
halt
criminal
sentencing

[ABC
News]


Earlier
:

Sam
Alito
Laments
It’s
Getting
So
You
Can’t
Take
All-Expense
Paid
Luxury
Vacations
Funded
By
Billionaires
Anymore


Donald
Trump
Demands
SCOTUS
Do
Him
A
Favor
Though




HeadshotJoe
Patrice
 is
a
senior
editor
at
Above
the
Law
and
co-host
of

Thinking
Like
A
Lawyer
.
Feel
free
to email
any
tips,
questions,
or
comments.
Follow
him
on Twitter or

Bluesky

if
you’re
interested
in
law,
politics,
and
a
healthy
dose
of
college
sports
news.
Joe
also
serves
as
a

Managing
Director
at
RPN
Executive
Search
.

7 Tech Challenges Facing Financial Services Law Departments – Above the Law

Though
it
may
seem
like
centuries
ago,
it
was
only
November
2022
when
the
launch
of
ChatGPT
made
harnessing
AI
a
central
focus
of
the
corporate
world.

Ever
since,
law
departments
of
all
sizes
and
in
all
industries
have
been
tasked
with
adopting
the
technology
and
realizing
the
benefits
it
can
provide.

In
financial
services
in
particular,
there
are
myriad
potential
upsides
for
law
departments.

But
as
with
any
new
technology,
there
is
an
apprehensiveness
surrounding
the
risks
of
bringing
it
on.
There’s
also
a
lack
of
awareness
about
all
that
it
can
accomplish.

In
this
white
paper
presented
with
our
friends
at
Relativity,
we
explore
seven
challenges
to
tech
adoption
faced
by
in-house
law
departments,
particularly
in
the
financial
services
industry.

We
also
look
at
some
steps
lawyers
should
consider
to
move
toward
their
desired
outcomes.

Biglaw Firms In California Close Their Offices, Shift To Remote Work Amid Deadly Blazes – Above the Law

(Photo
by
ROBYN
BECK/AFP
via
Getty
Images)

As
Southern
California
is
ravaged
by
life-threatening
wildfires,
Biglaw
firms
across
the
region
affected
by
the
dangerous
Palisades
Fire

which
at
last
check
was
0%
contained
thanks
to
fiercely
whipping
winds

have
opted
to
close
their
offices
and
transition
employees
to
remote
work.

Firms
with
offices
in
Los
Angeles
and
Santa
Monica
are
taking
extra
steps
to
make
sure
that
their
lawyers
and
staff
will
be
safe
during
this
natural
disaster.

The
Recorder

has
additional
details:

Orrick,
Herrington
&
Sutcliffe
closed
its
offices
in
Los
Angeles
and
Santa
Monica
on
Wednesday,
a
firm
spokesperson
told
The
Recorder.
The
firm’s
Santa
Monica
office,
at
631
Wilshire
Blvd.,
was
in
a
Level
2
evacuation
warning
zone
as
of
Wednesday
afternoon,
according
to
data
from
nonprofit
incident
tracker Watch
Duty
.

Thompson
Hine’s
Santa
Monica
office,
near
the
Brentwood
Country
Club
at
3130
Wilshire
Blvd.,
was
not
in
an
evacuation
zone
but
adjacent
to
an
evacuation
warning
area.
The
firm
said
it
closed
the
office
and
allowed
all
staff
to
work
remotely
on
Wednesday.

John
Conkle,
Thompson
Hine’s
Los
Angeles
partner
in
charge,
issued
the
following
statement:
“In
light
of
the
recent
fires
in
Los
Angeles,
Thompson
Hine
is
taking
proactive
measures
to
ensure
the
safety
and
well-being
of
our
lawyers
and
staff,
which
remains
our
highest
priority.
To
prioritize
the
safety
and
well-being
of
our
people,
the
Los
Angeles
office
is
currently
operating
in
business
continuity
mode.
This
approach
allows
us
to
maintain
our
operations
effectively
while
ensuring
that
our
team
members
are
safe
and
supported.”

Goodwin
Procter
and
Cozen
O’Connor
have
offices
located
within
Santa
Monica’s
evacuation
warning
zone,
but
neither
firm
could
be
reached
for
comment
on
their
plans
for
their
ongoing
office
operations
amid
the
blaze.
Cooley’s
Santa
Monica
office
is
under
a
red
flag
warning
for
poor
air
quality,
and
the
firm
has
temporarily
closed
its
affected
office.

We
here
at
Above
the
Law
extend
our
thoughts
to
all
law
firm
attorneys
and
staff
members
affected
by
the
raging
wildfires
in
California.


Law
Firms
Close
Southern
California
Offices
Amid
Devastating
Wildfires

[The
Recorder]



Staci ZaretskyStaci
Zaretsky
 is
a
senior
editor
at
Above
the
Law,
where
she’s
worked
since
2011.
She’d
love
to
hear
from
you,
so
please
feel
free
to

email

her
with
any
tips,
questions,
comments,
or
critiques.
You
can
follow
her
on BlueskyX/Twitter,
and Threads, or
connect
with
her
on LinkedIn.

Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More – MedCity News

A
case
can
be
made
that
metabolic
medicine
was
the
theme
of
the
life
sciences
industry
in
2024.
Insatiable
market
demand
fueled
rocketing
revenue
growth
for
Novo
Nordisk,
which
makes
Wegovy,
and
Eli
Lilly,
maker
of
Zepbound.
This
commercial
success
is
paving
the
way
for
metabolic
drug
research
more
broadly,
as
would-be
contenders
aim
to
develop
new
and
better
products
for
weight
loss.

While
this
space
has
become
active
and
crowded,
not
so
long
ago,
obesity
drugs
were
a
research
desert.
Omar
Khalil,
managing
director
of
Sante
Ventures,
remembers
those
days.

“Five
years
ago,
you
couldn’t
get
a
meeting
with
a
[venture
capitalist]
if
you
said
you
were
developing
a
drug
for
weight
loss,”
he
said.
“It
was
a
space
that
investors
did
not
want
to
touch,
given
the
failures
and
the
challenges
with
getting
drugs
approved.
With
the
success
of
Novo
and
Lily
getting
their
drugs
approved,
that’s
obviously
changed
drastically.”

Not
surprisingly,
there’s
enough
momentum
in
metabolic
medicines
to
carry
over
into
2025.
The
class
of
expensive
GLP-1
drugs
touches
on
broader
themes
that
will
affect
the
life
sciences
in
the
coming
year,
such
as
drug
pricing
and
regulation.

Deloitte’s
survey
of
150
C-suite
executives
for
its

2025
Life
Sciences
Outlook
report

shows
that
pricing
and
access
to
drugs
and
medical
devices
is
the
most
significant
issue:
47%
expect
pricing
and
access
to
significantly
affect
their
strategies
while
49%
expect
a
moderate
impact.


What’s
Ahead
in
Drug
Pricing

The
Centers
for
Medicare
and
Medicaid
Services
has
already

selected
the
first
10
drugs
for
the
negotiation
program
established
by
the
Inflation
Reduction
Act
(IRA)
.
Those
prices
won’t
take
effect
until
2026.
In
2025,
up
to
15
more
drugs
under
Medicare
Part
D
will
be
selected
for
the
negotiation
program.
Novo
Nordisk’s
Wegovy
and
Lilly’s
Zepbound
won’t
be
covered
by
these
negotiations.
But
they
could
still
come
under
CMS’s
purview
under
a
policy
change
proposed
by
the
Biden
administration.

Federal
law
does
not
permit
Medicare
to
cover
obesity
drugs.
But
the
Biden
administration
has
proposed
reinterpreting
the
law,
classifying
GLP-1s
as
chronic
disease
medicines
rather
than
obesity
drugs.
It’s
unclear
what
the
Trump
administration
will
do.
Robert
F.
Kennedy
Jr.,
Trump’s
pick
to
lead
the
Department
of
Health
and
Human
Services,
opposes
such
drugs.
But
Elon
Musk,
who
is
leading
the
Department
of
Government
Efficiency,
has
expressed
support
for
obesity
drugs
as
a
way
to
lower
healthcare
costs.

In
a
Dec.
5
online
media
briefing
after
the
Citi
Global
Healthcare
Conference,
Citi
analyst
Geoff
Meacham
said
one
looming
drug
price
question
is
whether
Trump
adopts
most
favored
nation
pricing,
a
policy
proposed
in
his
first
term
that
would
cap
Medicare
drug
prices
at
the
levels
paid
by
other
countries.
He
added
that
he
does
not
think
a
repeal
of
the
IRA
is
in
the
cards.

As
for
Trump’s
unconventional
nominees,
Meacham
didn’t
think
that
Mehmet
Oz
leading
the
Centers
for
Medicare
and
Medicaid
Services
and
Martin
Markary
at
the
FDA
would
be
very
controversial
or
unsettling.
But
the
selection
of
RFK
for
HHS
raises
uncertainty,
he
noted.
Despite
all
the
handwringing
and
fear,
Meacham
does
not
see
radical
changes
brewing.

“We’re
not
of
the
view
from
a
policy
perspective
that
drugs
are
going
to
be
pulled
from
the
market,”
he
said.
“We’re
not
of
the
view
that
the
drug
review
process
will
be
changed.”


Regulatory
Outlook

Deloitte
said
most
some
industry
executives
are
bracing
for
business
volatility.
Some
of
that
volatility
could
come
from
changes
to
how
the
FDA
and
CMS
interpret
laws
due
to
the

U.S.
Supreme
Court’s
overturning
of
the
Chevron
doctrine
,
Deloitte
said.
Under
this
decades-old
doctrine,
in
matters
where
a
law
was
ambiguous,
courts
deferred
to
the
expertise
of
federal
agencies.
Deloitte
said
it’s
unclear
whether
courts
will
continue
to
defer
to
government
agencies
for
their
statutory,
scientific,
and
technical
interpretations
of
laws.

To
Khalil,
the
biggest
regulatory
concern
to
investors
is
anything
that
leads
to
less
stability
or
predictability
within
the
FDA.

“It’s
not
so
much
whether
it’s
less
onerous
or
more
onerous,”
Khalil
said
of
regulation.
“It’s,
is
it
less
predictable?
Is
the
path
to
approval
something
we
can
understand
and
underwrite?
If
it’s
less
predictable,
or
if
there’s
an
exodus
of
FDA
employees,
or
if
review
times
are
extended,
those
dynamics
could
certainly
impact
the
biotech
market
and
certainly
reduce
inflows
into
the
market
if
people
don’t
see
a
predictable
path
or
a
regulatory
process
that’s
well
understood.”

To
the
extent
that
there
is
political
or
regulatory
uncertainty,
it
hasn’t
tamped
down
interest
in
metabolic
disorder
drugs.
According
to
the
Deloitte
report,
the
success
of
GLP-1
obesity
drugs
have
revitalized
interest
in
general
medicines

small
molecule
drugs
that
treat
common
conditions
(Currently
available
GLP-1
medications
are
injectable
peptides,
not
oral
small
molecules,
but
there
are
small
molecules
in
various
stages
of
development
for
obesity).

Deloitte
notes
that
many
companies
are
trying
to
capture
a
share
of
the
$200
billion
GLP-1
drug
market.
Beyond
obesity,
potential
indications
for
these
drugs
include
sleep
apnea,
addiction,
Alzheimer’s
disease,
and
metabolic
dysfunction-associated
steatohepatitis
(MASH).
New
medications
for
these
disorders
could
have
far-reaching
effects
by
reducing
demand
for
medical
devices
and
surgical
procedures
related
to
diabetes
and
obesity,
Deloitte
said
in
its
report.


Digital
Transformation
Led
by
AI

Artificial
intelligence
is
a
big
part
of
the
digital
transformation
underway
in
the
life
sciences
industry,
according
to
Deloitte.
Survey
respondents
said
technologies
employing
generative
AI
are
enhancing
products,
services,
operations,
and
strategic
decision
making.
About
60%
of
executives
said
they
plan
to
increase
investments
in
generative
AI
and/or
digital
transformation.
This
suggests
that
companies
are
moving
beyond
initial
pilot
projects
and
beginning
to
realize
substantial
value
from
adopting
these
technologies
at
scale,
according
to
Deloitte.
The
firm
adds
that
generative
AI
in
particular
is
seen
as
having
more
transformational
potential
than
previous
digital
innovations
because
it
can
reduce
R&D
costs
and
streamline
back-office
operations,
among
other
benefits.

The
clinical
trials
sector
is
one
area
realizing
the
benefits
of
AI-driven
technologies.
By
the
end
of
2025,
AI
will
go
from
being
used
in
certain
situations
to
being
a
main
component
of
clinical
trial
operations,
contends
Jeff
Sidell,
chief
technology
officer
of
Advarra,
a
clinical
trials
services
and
technology
company.
Generative
AI
already
enables
automation
of
labor-intensive
tasks
but
there
is
also
promise
in
predictive
analytics
to
forecast
outcomes,
optimize
allocation
of
resources,
and
streamline
timelines,
he
said.
These
technologies
can
also
be
used
to
extract
key
information
from
documents,
reducing
manual
entry
errors.

“Additional
use
cases
that
will
become
more
common
this
year
include
using
AI
to
analyze
past
trials
and
recommend
improvements
based
on
data
patterns,”
Sidwell
said.
“Site
selection
will
also
benefit
from
AI
by
identifying
optimal
sites
with
a
greatest
likelihood
for
patient
recruitment
success,
considering
factors
like
demographics,
past
performance,
and
patient
availability.”


The
Investment
Outlook
for
2025

2024
was
a
rebuilding
year
for
the
IPO
market,
according
to
Renaissance
Capital.
The
IPO
research
firm
counted
146
companies
that
went
public
across
a
range
of
industries.
Those
companies
raised
$29.6
billion,
which
was
50%
more
compared
to
the
prior
year.
Even
so,
deal
flow
was
slow
as
companies
repeatedly
pushed
back
IPO
timelines
amid
uncertainty
about
interest
rate
cuts
and
other
signs
of
economic
volatility.
Renaissance
expects
2025
will
be
a
better
year
for
IPOs.

“While
some
may
be
skeptical
that
a
pickup
is
once
again
‘right
around
the
corner,’
the
IPO
market
has
a
stronger
foundation
now
than
at
any
point
since
the
Covid
bubble
burst
in
2022,”
the
firm
said
in
its

2024
annual
review
.
“High
returns,
renewed
optimism,
and
a
steady
flow
of
private
company
news
point
to
more
deals
on
the
horizon,
and
while
we
don’t
expect
a
blowout
year,
IPO
activity
should
finally
normalize
fully
in
2025.”

Sante
Ventures’
Khalil
noted
key
differences
in
the
kind
of
biotech
company
that
can
go
public
now
versus
a
few
years
ago.
Many
companies
that
went
public
during
the
IPO
boom
were
early
stage
or
even
preclinical.
Some
had
what
amounted
to
an
interesting
science
project
or
scientific
thesis
that
was
not
well
supported
by
clinical
data,
he
said.
Investors
welcomed
these
newly
public
companies
in
part
because
extremely
low
interest
rates
made
it
easy
to
invest.

The
capital
available
to
biotech
companies
has
since
become
more
constrained,
Khalil
said.
Consequently,
biotechs
are
more
amenable
to
striking
deals
with
big
pharma.
The
fundamentals
of
investing
in
biotech
are
not
revenue
and
profitability,
but
rather
clinical
data,
he
said.
The
companies
best
positioned
to
go
public
have
one
or
more
assets
in
late-stage
clinical
development.
Companies
that
achieve
clinical
proof
of
concept
against
a
well-validated
target
are
able
to
raise
capital
to
fund
their
research
to
late-stage
development,
Khalil
said.
But
earlier-stage
companies
are
still
struggling
to
raise
financing.

Macroeconomic
factors
could
be
key
to
shaping
investment
trends
in
the
new
year.
Deloitte
said
36%
of
survey
respondents
were
evaluating
the
potential
impact
of
inflation,
economic
recession,
and
supply
chain
and
manufacturing
disruption.
According
to
Khalil,
improving
macroeconomic
conditions
could
improve
the
investment
climate.

“As
inflation
has
gotten
more
under
control
and
interest
rates
have
started
to
come
down,
that’s
started
to
loosen
some
of
the
capital
that’s
been
stuck
on
the
sidelines
for
some
time,”
he
said.


In
Conclusion…

There’s
optimism
for
the
life
sciences
in
the
coming
year.
Deloitte
said
75%
of
survey
respondents
expressed
that
sentiment,
based
on
their
expectations
for
strong
growth
and
margin
expansion
in
2025.
The
outlook
for
scientific
advances
is
also
positive.
Oncology
once
dominated
drug
pipelines,
and
unmet
medical
needs
means
there
is
still
research
interest
in
this
space.
But
research
and
investor
interest
is
also
expanding
to
immunology,
which
has
emerged
as
another
hot
therapeutic
area.

Meanwhile,
metabolic
disease
drugs
are
already
demonstrating
growth
potential
beyond
obesity
and
type
2
diabetes.
As
2024
drew
to
a
close,
the

FDA
approved
Lilly’s
Zepbound
for
obstructive
sleep
apnea,
making
the
product
the
first
drug
therapy
approved
for
the
chronic
disorder
.
Lilly
and
others
are
working
furiously
to
expand
metabolic
medicines
to
more
indications.
That
could
very
well
become
a
key
theme
of
2025.


Photo:
Stuart
Ritchie,
Getty
Images

Morning Docket: 01.09.25 – Above the Law

(Photo
by
Erin
Schaff-Pool/Getty
Images)

*
Alito
and
Trump
had
a
chat
before
Trump
asked
Supreme
Court
to
have
his
state
law
convictions
thrown
out.
[

CBS
News
]

*
Florida
lawyer
allegedly
soaked
legal
documents
in
synthetic
marijuana
to
distribute
to
inmates.
And
you
thought
PACER
was
expensive.
[NY
Post
]

*
Paralegal
barred
from
future
work
in
the
industry
after
trying
to
cover
up
missed
emails.
[LegalCheek]

*
Justice
Department
not
releasing
the
full
special
counsel
report
into
Trump’s
classified
document
collection.
Technically,
the
Supreme
Court
says
it
can’t
be
illegal
of
Biden
orders
it
released
himself…
just
sayin’.
[Reuters]

*
The
Corporate
Transparency
Act
might
be
the
least
intrusive
anti-money
laundering
check
ever
devised…
but
Republican
judges
are
working
overtime
to
kill
it
on
behalf
of
their
wealthy
fan
club.
[Bloomberg
Law
News
]

*
Delaware
awards
$176M
legal
fee
in
Musk
compensation
case.
Which
is
not
the
$5B
they
asked
for
after
saving
shareholders
over
$50B,
but
that’s
sort
of
a
testament
to
how
bonkers
Musk’s
request
was
in
the
first
place.
[Law360]

*
In-house
counsel
getting
flack
for
paying
higher
billing
rates
when
lawyers
matched
the
inflation
everyone
else
did.
[Corporate
Counsel
]

Discrimination Lawsuit Turns To The Right – See Also – Above the Law


Scratch
The
Stuff
About
Gangsta
Rap…
I’m
A
Veteran:


William
Brown
changes
the
framing
of
his
lawsuit
.


Republicans
Are
Mad
At
The
ABA’s
Diversity
Standards:


Any
mention
seems
to
be
too
much
.


About
The
Lawyer
Of
The
Year…:


New
congratulations
are
in
order
!


Math
Makes
For
Due
Process:


There’s
a
complication
with
Charlie
Adelson’s
sentencing
.


Even
The
DOJ
Says
Rent
Is
Too
High:


New
plaintiffs
added
to
antitrust
case
.

Spouse Of MAGA Judge Gets Nod For Top DOJ Position – Above the Law

(Photo
by
David
Becker/Getty
Images)



Ed.
Note:

Welcome
to
our
daily
feature

Trivia
Question
of
the
Day!


Who
was
selected
by
Donald
Trump
to
be
the
Department
of
Justice
Chief
of
Staff,
though
potential
conflicts
may
arise
with
the
pick
since
his
wife
was 
appointed
to
the
federal
judiciary
during
Trump’s
first
term
in
office?


Hint:
Trump
praised
the
pick
as
a
“MAGA
warrior”
who
will
“help
bring
accountability,
integrity,
and
Justice
back
to
the
DOJ.”



See
the
answer
on
the
next
page.